Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Indaptus Therapeutics Inc
(NQ:
INDP
)
1.647
-0.013 (-0.76%)
Streaming Delayed Price
Updated: 3:37 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Indaptus Therapeutics Inc
< Previous
1
2
3
Next >
Recap: Indaptus Therapeutics Q4 Earnings
March 21, 2022
Indaptus Therapeutics (NASDAQ:INDP) reported its Q4 earnings results on Monday, March 21, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 09, 2022
Gainers
Via
Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
January 04, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 03, 2022
Gainers Indaptus Therapeutics (NASDAQ:INDP
Via
Benzinga
21 Stocks Moving In Friday's Mid-Day Session
December 31, 2021
Gainers Nutriband Inc. (NASDAQ: NTRB) shares jumped 120.2% to $8.61 after the company announced the Korean Intellectual Property Office has fully issued its patent titled "...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 29, 2021
Gainers Cumberland (NASDAQ:CPIX) share...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 29, 2021
Gainers Krystal Biotech (NASDAQ:
Via
Benzinga
Maxim Upgrades Indaptus Therapeutics To Buy
October 19, 2021
Maxim analyst has upgraded Indaptus Therapeutics Inc (NASDAQ: INDP) to Buy from Hold with a $16 price target, an upside of over 100%. Analyst Jason McCarthy says,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
Upgrades Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc (NASDAQ:
Via
Benzinga
48 Biggest Movers From Yesterday
September 21, 2021
Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 20, 2021
Gainers Atea Pharmaceuticals (NASDAQ:AVIR) shares increased by 13.83% to $29.86 during Monday's regular session. Trading volume for this security as of 12:30 EST is 3....
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
September 20, 2021
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 17, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 16, 2021
Gainers Stealth BioTherapeutics (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 16, 2021
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
September 16, 2021
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 16, 2021
Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The company's market cap stands at $152.7 million. Phio...
Via
Benzinga
53 Biggest Movers From Yesterday
September 16, 2021
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 15, 2021
Gainers Larimar Therapeutics (NASDAQ:
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 250 Points; GreenSky Shares Spike Higher
September 15, 2021
Toward the end of trading Wednesday, the Dow traded up 0.72% to 34,827.73 while the NASDAQ rose 0.58% to 15,125.38. The S&P also rose, gaining 0.82% to 4,479.33. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
INDP Stock: The Patent News That Has Indaptus Therapeutics Skyrocketing Today
September 15, 2021
Shares of INDP stock are skyrocketing on Wednesday after the U.S. Patent and Trademark Office made a big move for Indaptus Therapeutics.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 15, 2021
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares...
Via
Benzinga
Mid-Day Market Update: Crude Oil Surges 3%; Kaival Brands Shares Plunge
September 15, 2021
Midway through trading Wednesday, the Dow traded up 0.16% to 34,633.63 while the NASDAQ fell 0.02% to 15,035.07. The S&P also rose, gaining 0.19% to 4,451.27. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
38 Stocks Moving In Wednesday's Mid-Day Session
September 15, 2021
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why Are Indaptus Therapeutics Shares Shooting Higher On Wednesday?
September 15, 2021
The United States Patent and Trademark Office has issued a notice of patent allowance to Indaptus Therapeutics Inc's (NASDAQ: INDP) platform technology....
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Mid-Morning Market Update: Markets Mixed; Industrial Production Rises 0.4% In August
September 15, 2021
Following the market opening Wednesday, the Dow traded up 0.13% to 34,621.78 while the NASDAQ fell 0.25% to 14,999.72. The S&P also rose, gaining 0.03% to 4,444.41. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 15, 2021
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.